Bayer Warning Letters Reinforce FDA Ban On Supplement/Drug Combinations
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA could seize combo products and request an injunction against distribution and sales if Bayer fails to satisfy agency questions.